Keltouma Driouch
Inventor
Stats
- 0 US patents issued
- 3 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 3 US Applications Filed
- 21 Total Citation Count
- May 11, 2021 Most Recent Filing
- Feb 26, 2008 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
INSTITUT CURIE | 1
| 2011
|
L'INSTITUT CURIE | 1
| 2008
|
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | 1
1 | 2008
2011 |
Inventor Addresses
Address | Duration |
---|---|
Les Lilas, FR | May 06, 10 - May 06, 10 |
Paris, FR | Jun 15, 23 - Jun 15, 23 |
Saint-Cloud, FR | Aug 29, 13 - Aug 29, 13 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 1 |
C12Q: | MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS | 2 |
C40B: | COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2023/0184,775 | 2023 | KINDLIN-1 AS A MARKER OF SENSITIVITY TO EGFR/RAS PATHWAY INHIBITORS | 0 |
2013/0224,192 | 2013 | METHOD FOR THE PROGNOSIS OF THE PROGRESSION OF CANCER | 3 |
2010/0113,297 | 2010 | METHOD FOR PREDICTING THE OCCURRENCE OF METASTASIS IN BREAST CANCER PATIENTS | 14 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.